{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:12:25Z","timestamp":1761765145216},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jash.2009.01.003","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T23:42:48Z","timestamp":1238456568000},"page":"184-191","source":"Crossref","is-referenced-by-count":9,"title":["Aldosterone receptor antagonism reduces urinary C-reactive protein excretion in angiotensin II\u2013infused, hypertensive rats"],"prefix":"10.1016","volume":"3","author":[{"given":"Rudy M.","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mamalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Gabriel","family":"Navar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2009.01.003_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2009.01.003_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-7125(05)70211-X","article-title":"C-reactive protein, inflammation, and coronary risk","volume":"84","author":"Morrow","year":"2000","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jash.2009.01.003_bib3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in Women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2009.01.003_bib4","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1001\/jama.290.22.2945","article-title":"C-reactive protein and the risk of developing hypertension","volume":"290","author":"Sesso","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2009.01.003_bib5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.104.508465","article-title":"C-reactive protein in heart failure: prognostic value and the effect of valsartan","volume":"112","author":"Anand","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2009.01.003_bib6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCULATIONAHA.106.664854","article-title":"C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice","volume":"115","author":"Vongpatanasin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2009.01.003_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.atherosclerosis.2006.05.025","article-title":"Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients","volume":"192","author":"Kim","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jash.2009.01.003_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1524-6175.2005.05248.x","article-title":"The effects of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension","volume":"8","author":"King","year":"2006","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jash.2009.01.003_bib9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.RES.0000182677.89816.38","article-title":"Complement activation in angiotensin II-induced organ damage","volume":"97","author":"Shagdarsuren","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jash.2009.01.003_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.atherosclerosis.2006.09.007","article-title":"Angiotensin II-induced C-reactive protein generation: inflammatory role of vascular smooth muscle cells in atherosclerosis","volume":"193","author":"Peng","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jash.2009.01.003_bib11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2009.01.003_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2009.01.003_bib13","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.jash.2009.01.003_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cardiores.2003.11.037","article-title":"Review of aldosterone- and angiotensin II-induced target organ damage and prevention","volume":"61","author":"Struthers","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jash.2009.01.003_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2009.01.003_bib16","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0029-7844(02)02251-2","article-title":"Evidence of fetal C-reactive protein urinary excretion in early gestation","volume":"101","author":"Raio","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jash.2009.01.003_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0022-1759(78)90203-X","article-title":"C-reactive protein: purification by affinity chromatography and physicochemical characterization","volume":"23","author":"Volanakis","year":"1978","journal-title":"J Immunol Met"},{"key":"10.1016\/j.jash.2009.01.003_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3181\/00379727-136-35323","article-title":"Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide","volume":"136","author":"Volanakis","year":"1971","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jash.2009.01.003_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000075945","article-title":"Effects of eplerenone on heart and kidney in\u00a0two-kidney, one-clip rats","volume":"24","author":"Hao","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jash.2009.01.003_bib20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.0000157408.43807.5a","article-title":"Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKC{epsilon}-MAPK-p90RSK, and rho-kinase pathway","volume":"45","author":"Kobayashi","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2009.01.003_bib21","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/en.141.10.3871","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.jash.2009.01.003_bib22","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1089\/ars.2005.7.1294","article-title":"Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences","volume":"7","author":"Sanz-Rosa","year":"2005","journal-title":"Antioxid Redox Signaling"},{"key":"10.1016\/j.jash.2009.01.003_bib23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.ATV.0000204635.75748.0f","article-title":"Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation","volume":"26","author":"Suzuki","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jash.2009.01.003_bib24","doi-asserted-by":"crossref","first-page":"F139","DOI":"10.1152\/ajprenal.00504.2006","article-title":"Aldosterone receptor antagonism exacerbates intrarenal angiotensin II augmentation in Ang II-dependent hypertension","volume":"293","author":"Ortiz","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jash.2009.01.003_bib25","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4049\/jimmunol.124.3.1396","article-title":"Comparative studies on the binding properties of human and rabbit C-reactive proteins","volume":"124","author":"Oliveira","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.jash.2009.01.003_bib26","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1073\/pnas.74.8.3148","article-title":"Primary structure of human C-reactive protein","volume":"74","author":"Oliveira","year":"1977","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jash.2009.01.003_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0161-5890(01)00042-6","article-title":"Human C-reactive protein: expression, structure, and function","volume":"38","author":"Volanakis","year":"2001","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jash.2009.01.003_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.carpath.2006.04.006","article-title":"C-reactive protein: a nontraditional serum marker of cardiovascular risk","volume":"16","author":"De Ferranti","year":"2007","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jash.2009.01.003_bib29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.metabol.2005.03.022","article-title":"High-sensitive C-reactive protein, tumor necrosis factor [alpha], and cardiovascular risk factors before and after weight loss in obese children","volume":"54","author":"Reinehr","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.jash.2009.01.003_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/01.HYP.0000252664.24294.ff","article-title":"Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women","volume":"49","author":"Sesso","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2009.01.003_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijcard.2005.01.068","article-title":"The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen","volume":"106","author":"Wilson","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jash.2009.01.003_bib32","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","article-title":"Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs","volume":"103","author":"Pasceri","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2009.01.003_bib33","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2009.01.003_bib34","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated low-density lipoprotein uptake by macrophages: implications for atherosclerosis","volume":"103","author":"Zwaka","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2009.01.003_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.mehy.2003.12.014","article-title":"C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases","volume":"62","author":"Li","year":"2004","journal-title":"Med Hypoth"},{"key":"10.1016\/j.jash.2009.01.003_bib36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.104.9.974","article-title":"C-reactive protein: linking inflammation to cardiovascular complications","volume":"104","author":"Yeh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2009.01.003_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1999.tb07789.x","article-title":"Chronic angiotensin II infusion promotes atherogenesis in low-density lipoprotein receptor -\/- mice","volume":"892","author":"Daugherty","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jash.2009.01.003_bib38","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hq0901.095547","article-title":"Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized LDL: a possible role for interleukin-6","volume":"21","author":"Keidar","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jash.2009.01.003_bib39","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/01.ATV.0000145607.03879.e0","article-title":"Angiotensin II amplifies macrophage-driven atherosclerosis","volume":"24","author":"Nobuhiko","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jash.2009.01.003_bib40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.atherosclerosis.2005.08.009","article-title":"Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice","volume":"186","author":"Takaya","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jash.2009.01.003_bib41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijcard.2006.05.069","article-title":"Yee K-M, Struthers AD. Effect of spironolactone on C-reactive protein levels in patients with heart disease","volume":"117","author":"Godfrey","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jash.2009.01.003_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1067\/mhj.2001.116699","article-title":"Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis","volume":"142","author":"Prasad","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jash.2009.01.003_bib43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/01.fjc.0000185783.00391.60","article-title":"Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension","volume":"46","author":"Manabe","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jash.2009.01.003_bib44","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/ndt\/gfl112","article-title":"Early markers of inflammation in a high angiotensin II state\u2014results of studies in Bartter's\/Gitelman's syndromes","volume":"21","author":"Davis","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2009.01.003_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semnephrol.2003.11.008","article-title":"Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II","volume":"24","author":"Agarwal","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jash.2009.01.003_bib46","doi-asserted-by":"crossref","first-page":"F80","DOI":"10.1152\/ajprenal.00090.2005","article-title":"Enhanced superoxide generation modulates renal function in Ang II-induced hypertensive rats","volume":"290","author":"Kopkan","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jash.2009.01.003_bib47","doi-asserted-by":"crossref","first-page":"R893","DOI":"10.1152\/ajpregu.00491.2002","article-title":"Role of oxidative stress in angiotensin-induced hypertension","volume":"284","author":"Reckelhoff","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jash.2009.01.003_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease","volume":"98","author":"Ferrario","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2009.01.003_bib49","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jash.2009.01.003_bib50","doi-asserted-by":"crossref","first-page":"H336","DOI":"10.1152\/ajpheart.01307.2005","article-title":"Ang II-induced cardiac molecular and cellular events: role of aldosterone","volume":"291","author":"Zhao","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jash.2009.01.003_bib51","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.HYP.0000254486.00883.3d","article-title":"Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice","volume":"49","author":"Armando","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2009.01.003_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.HYP.37.1.77","article-title":"Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats","volume":"37","author":"Nishiyama","year":"2001","journal-title":"Hypertension"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171109000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171109000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T06:18:58Z","timestamp":1710224338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171109000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1933171109000084"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2009.01.003","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}